Author:
Gangi Alexandra,Anaya Daniel A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference40 articles.
1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72. https://doi.org/10.1200/JCO.2007.15.4377.
2. • Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42. https://doi.org/10.1001/jamaoncol.2017.0589 A retrospective, population-based study (N = 64,971) using SEER data was conducted to determine whether epidemiology of NET changed over time from 1973 to 2012.
3. • International Agency for Research on Cancer (IARC). WHO classification of tumours of endocrine organs 4th ed. Medicine (Book 10). World Health Organization. 2017; This authoritative, concise reference book provides an international standard for oncologists/pathologists and will serve as an indispensable guide for use in the design of SB NET-related studies evaluating response to therapy and clinical outcome.
4. • Scott AT, Howe JR. Management of small bowel neuroendocrine tumors. Surg Oncol Clin N Am. 2020;29(2):223–41. https://doi.org/10.1016/j.soc.2019.11.006 A recent review paper that summarizes surgical managment principles in SB NET.
5. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249(1):63–71. https://doi.org/10.1097/SLA.0b013e31818e4641.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献